Fluence awarded third Aspiral contract in China

Company News

by Anna Napoli

Water and wastewater treatment company, Fluence Corporation (ASX:FLC) has been awarded a contract to deliver an Aspiral smart packaged plant solution in China.

The new contract is for a large wastewater plant in the Guizhou province.

It’s the third contract secured by Fluence’s Chinese partner, Jinzi Environment Company.

Fluence says Jinzi recognises the significant advantages of Aspiral for the treatment of wastewater in China.

Aspiral is a range of wastewater treatment solutions, based on its innovative Membrane Aerated Biofilm Reactor (MABR) technology.

Shares in Fluence Corporation (ASX:FLC)  are trading 3.85 per cent higher to 41 cents.

 

Anna Napoli

Finance News Network
Anna joined FNN February 2018 and also works with Channel 7 as a freelance producer. Anna has also worked as a lawyer and lecturer. She has also presented news updates for interstate news with Southern Cross Austereo.